Stopped: Failure to recruit patients meeting inclusion criteria.
This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Peak TCD velocities
Timeframe: daily from admission to discharge (approx 5-7 days)
Duration of elevated TCD velocities
Timeframe: daily from admission to discharge (approx 5-7 days)
Normalization of TCD velocities
Timeframe: daily from admission to discharge (approx 5-7 days)